Pradaxa Maker Awarded Summary Judgment in Calif. Coordinated Docket Action

SAN FRANCISCO — The judge presiding over the California coordinated Pradaxa docket has awarded Boehringer Ingelheim Pharmaceuticals Inc. summary judgment on a plaintiff’s inadequate warning claims, finding they are preempted by federal law.

In a Nov. 12 order, Judge Teri L. Jackson of the San Francisco County Superior Court said the plaintiff failed to prove there was relevant “newly acquired information” about the anti-clotting drug that would permit BI to change the drug’s label.

“Plaintiff’s evidence is conditional and/or preliminary, without the sufficient degree of scientific validity required to constitute newly acquired information, does not present any new or different …